Future of human mitochondrial DNA editing technologies.

N Verechshagina, N Nikitchina,Y Yamada, Н Harashima,M Tanaka,K Orishchenko,I Mazunin

MITOCHONDRIAL DNA PART A(2019)

引用 20|浏览16
暂无评分
摘要
ATP and other metabolites, which are necessary for the development, maintenance, and functioning of bodily cells are all synthesized in the mitochondria. Multiple copies of the genome, present within the mitochondria, together with its maternal inheritance, determine the clinical manifestation and spreading of mutations in mitochondrial DNA (mtDNA). The main obstacle in the way of thorough understanding of mitochondrial biology and the development of gene therapy methods for mitochondrial diseases is the absence of systems that allow to directly change mtDNA sequence. Here, we discuss existing methods of manipulating the level of mtDNA heteroplasmy, as well as the latest systems, that could be used in the future as tools for human mitochondrial genome editing.
更多
查看译文
关键词
mitoRGEN,SpCas9,AsCpf1,mitoTALE,mitoRetron
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要